ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988